EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents

Pınar Poyraz Yılmaz, Necla Kulabaş, Arif Bozdeveci, Siva Krishna Vagolu, Mohd Imran iD, Esra Tatar, Şengül Alpay Karaoğlu, Dharmarajan Sriram, Ammar A Razzak Mahmood, İlkay Küçükgüzel iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Pınar Poyraz Yılmaz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Marmara University, İstanbul, Turkey. Hauptthemen laut MEDLINE: Thiadiazoles, Anti-Bacterial Agents, Fluoroquinolones, Thiazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty azole‐fluoroquinolone hybrids were designed and synthesized by conjugating thiazole and thiadiazole structures to ciprofloxacin and norfloxacin via a 2‐oxoethyl bridge. The structures and purities of the synthesized compounds were proven by spectral techniques. The antimycobacterial effects of target compounds 21–40 were tested against Mycobacterium tuberculosis H37Rv strain. Among the 20 synthesized compounds, 12 exhibited minimal inhibition concentration (MIC) values in the range of 1.56–25 μg/mL. Among the molecules screened for antimycobacterial effects, the most effective was compound 35 , a thiadiazole‐ciprofloxacin hybrid. The cytotoxic effect of this molecule was found to be lower than the reference drugs, and it was also determined to be a more effective inhibitor than ciprofloxacin and norfloxacin in the DNA‐gyrase supercoiling test. The antimicrobial effects of compounds 21–40 were screened by agar‐well diffusion and microdilution tests against Gram‐positive/negative bacteria, a fast‐growing mycobacterium, and two yeast strains. While most of the compounds tested showed antibacterial effects, the most effective fluoroquinolone derivative appeared to be compound 31 with an MIC value of < 0.63 μg/mL against all Gram‐negative bacteria tested. Azole‐fluoroquinolone hybrids 21–40 did not show any activity against non‐pathogenic Lactobacillus species and yeast‐like fungi, indicating that they have selective antibacterial and antimycobacterial activity, particularly against Gram‐negative bacteria. In silico molecular docking studies were conducted to uncover the interactions between lead compound 35 and the DNA gyrase proteins of M. tuberculosis and S. aureus . Additionally, a 100 ns molecular dynamics simulation was carried out to assess the stability of the complexes formed between compound 35 and both proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiadiazolesAnti-Bacterial AgentsFluoroquinolonesThiazolesMicrobial Sensitivity TestsMycobacterium tuberculosisDNA GyraseMolecular Docking SimulationHumansStructure-Activity Relationship

Stichwörter der Autor:innen

DNA‐gyraseantibacterial activityantituberculosis activityfluoroquinolonesmolecular docking

Substanzen

ThiadiazolesAnti-Bacterial AgentsFluoroquinolonesThiazolesDNA Gyrase

Autor:innen und Institutionen

  • Institute of Health Sciences, Marmara University, İstanbul, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey.
  • Department of Biology, Faculty of Arts and Sciences, Recep Tayyip Erdoğan University, Rize, Turkey.
  • Department of Microbiology, University of Oslo, Oslo, Norway.
  • Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Center for Health Research, Northern Border University, Arar, Saudi Arabia.

ORCID-Profile: Mohd Imran, İlkay Küçükgüzel

Zitieren

APA

Poyraz Yılmaz, P., Kulabaş, N., Bozdeveci, A., Vagolu, S. K., Imran, M., Tatar, E., Alpay Karaoğlu, Ş., Sriram, D., Mahmood, A. A. R., & Küçükgüzel, İ. (2025). Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70126

Vancouver

Poyraz Yılmaz P, Kulabaş N, Bozdeveci A, Vagolu SK, Imran M, Tatar E, et al. Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70126

BibTeX
@article{PoyrazYlmaz2025,
  author = {Poyraz Yılmaz, Pınar and Kulabaş, Necla and Bozdeveci, Arif and Vagolu, Siva Krishna and Imran, Mohd and Tatar, Esra and Alpay Karaoğlu, Şengül and Sriram, Dharmarajan and Mahmood, Ammar A Razzak and Küçükgüzel, İlkay},
  title = {Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70126}
}
Kostenlos starten →